Argatroban Injection
Product Images NDC 0143-9559

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 0143-9559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Arg Chem Structure (Argatroban Injection 1)

FDA Label Image

Figure 1 (Argatroban Injection 2)

FDA Label Image

Figure 2 (Argatroban Injection 3)

Figure 2 (Argatroban Injection 3)
This is a data table that provides information on the effect of using INR Warfarin Plus Argatroban on Thromboplastin A and Thromboplastin B measurements in 24 subjects. It also suggests that using Wartain INR can predict the INR levels accurately with an error margin of +0.4 units. There is no additional information available.*
FDA Label Image

Figure 3 (Argatroban Injection 4)

FDA Label Image

Figure 4 (Argatroban Injection 5)

FDA Label Image

2.5 mL Individual Carton Argatroban (Argatroban Injection 6)

2.5 mL Individual Carton Argatroban (Argatroban Injection 6)
Argatroban is a medication that is available in injection form with a strength of 250 mg per 2.5 mL vial (100 mg/mL). The purpose of Argatroban and any indications or uses are not provided in the given text.*
FDA Label Image

Argatroban 50 mL Vial Container Label (Argatroban Injection 7)

Argatroban 50 mL Vial Container Label (Argatroban Injection 7)
Argatroban is a medication that comes in injection form. It contains 1 mg of Macousessen Paoy and 52 g of Propyes and is intended for intravenous use. The solution may appear cloudy or contain precipitates. The injection is available in 60/50 mL (1 mg/mL) vials. The text also includes several typographical errors and is not properly formatted, making it difficult to understand in parts.*
FDA Label Image

50 mL Individual Carton (Argatroban Injection 8)

50 mL Individual Carton (Argatroban Injection 8)
This is a product description and usage instruction for Argatroban Injection. It is a single-dose vial containing 50 mg of Argatroban in 50 mL of solution, to be administered intravenously without dilution. The unused portion must be discarded. The medication should only be used for intravenous infusion and contains 1 mg of Argatroban, along with other ingredients. The container must be stored at controlled room temperature, and the product doesn't contain preservatives.*
FDA Label Image

Argatroban Injection 9

Argatroban Injection 9
This text provides information about a lot with the identification number ABCDET2345, an expiration date (EXp) which appears to be HHRYYYY, a Global Trade Item Number (GTIN) with the value 0301234567896, and a serial number (SN) with the value 12345678901234.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.